Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

VR-relaxation for ECT-related Anxiety

NCT: NCT07546526 · ENROLLING_BY_INVITATION

NCT IDNCT07546526
StatusENROLLING_BY_INVITATION
Start Date2026-03-12
Completion2032-12-31

Brief Summary

The goal of this clinical trial is to learn if there is an effect of Virtual Reality (VR) based-relaxation on electroconvulsive therapy (ECT)-related anxiety. The main questions it aims to answer are: * Does VR based-relaxation have an effect on anxiety in patients receiving ECT as part of routine clinical care? * Does VR based-relaxation have an effect on stress symptoms and heart rate in patients receiving ECT as part of routine clinical care? * Does depression severity have an effect on the effectivity of VR-based relaxation Researchers will compare VR-relaxation to relaxation breathing exercises and no relaxation to see if VR-based relaxation has an effect on ECT-related anxiety.

Frequently Asked Questions

What is VR-relaxation for ECT-related Anxiety?

VR-relaxation for ECT-related Anxiety is a clinical trial registered under NCT07546526. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT07546526?

The current status of NCT07546526 (VR-relaxation for ECT-related Anxiety) is: ENROLLING_BY_INVITATION.

When did VR-relaxation for ECT-related Anxiety start?

VR-relaxation for ECT-related Anxiety started on 2026-03-12.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.